Janet Leon, MD
Rheumatology · Louisville, KYNPI 1962504613
Payments from drug & device makers
Across 1,118 payments — averaging $17.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$5K
- AbbVie$3K
- Johnson & Johnson$2K
- UCB, Inc.$2K
- Novartis$2K
- AstraZeneca$1K
- plus $5K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 319 | $4,769 |
| AbbVie | 163 | $3,014 |
| Johnson & Johnson | 101 | $2,000 |
| UCB, Inc. | 98 | $1,822 |
| Novartis | 70 | $1,591 |
| AstraZeneca(2 entities) | 48 | $1,319 |
| E.r. Squibb & Sons, L.L.C. | 71 | $989 |
| Mallinckrodt Hospital Products Inc. | 35 | $916 |
| Pfizer | 51 | $626 |
| Lilly USA, LLC | 28 | $370 |
| Regeneron Healthcare Solutions, Inc. | 26 | $297 |
| Sandoz | 11 | $231 |
| Sanofi | 10 | $231 |
| Bristol Myers Squibb | 7 | $214 |
| Boehringer Ingelheim | 11 | $209 |
| Aurinia Pharma U.S., Inc. | 11 | $200 |
| Genentech USA, Inc. | 10 | $154 |
| ANI Pharmaceuticals, Inc. | 8 | $152 |
| Bayer | 1 | $123 |
| Pacira Therapeutics, Inc. | 7 | $110 |
| Sobi, Inc | 6 | $107 |
| GSK | 1 | $104 |
| Mallinckrodt Enterprises LLC | 5 | $98 |
| Organon | 6 | $83 |
| Antares Pharma, Inc. | 4 | $66 |
| Merck | 3 | $37 |
| Radius Health, Inc. | 2 | $29 |
| United Therapeutics Corporation | 1 | $27 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $13 |
| Hikma Pharmaceuticals USA | 1 | $11 |
| Orthogenrx Inc. | 1 | $11 |
How this compares
$19,940 in reported general payments places this provider in the 75th percentile of 81 rheumatology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Louisville
- Housam SarakbiLouisville$297K
- Gary CrumpLouisville$176K
- Benjamin BooneLouisville$80K
- Jacquelyn SmithLouisville$63K
- Lisa JuneLouisville$27K
- Carolyn GleasonLouisville$25K
- Steven SternLouisville$3K
- Heidi RogersLouisville$2K
- Mohamed JallohLouisville$2K
- Ami JoglekarLouisville$830
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.